Analyst Ranking
Top 2%
#101 out of 5515 analysts
Average Return
+27.42%
Win Rate
57%127 out of 221
Risk vs Reward
Poor
Good

Mark Massaro's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Genedx Holdings CorpWGS
+776.23%$10.39$91.04
2024-04-22 -
2025-04-21
Strong Buy
Genedx Holdings CorpWGS
+585.24%$17.07$116.97
2024-04-30 -
2025-04-29
Strong Buy
Caredx IncCDNA
+271.47%$13.53$50.26
2025-09-12 -
2026-09-11
Strong Buy
Caredx IncCDNA
+258.63%$15.01$53.83
2025-11-06 -
2026-09-18
Strong Buy
Caredx IncCDNA
+245.73%$15.57$53.83
2025-09-23 -
2026-09-18
Strong Buy

Mark Massaro Analyst Color

Get additional color on Mark Massaro's coverage of popular stocks

Mark Massaro's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ginkgo Bioworks Holdings IncDNA
8Strong Sell$5.00-36.55%Reiterates
17 days ago
Guardant Health IncGH
12Strong Buy$195.00+8.71%Reiterates
19 days ago
Mdxhealth SaMDXH
11Strong Buy$2.00+217.46%Maintains
a month ago
Tempus Ai IncTEM
11Strong Buy$80.00+2.77%Maintains
a month ago
Freenome IncFRNM
1Strong Buy$17.00-0.64%Initiates Coverage On
a month ago
Lucid Diagnostics IncLUCD
7Strong Buy$2.50+218.07%Reiterates
a month ago
Alpha Teknova IncTKNO
2Strong Buy$8.00+2.70%Upgrades
a month ago
Natera IncNTRA
15Strong Buy$320.00-13.37%Maintains
a month ago
Billiontoone IncBLLN
5Strong Buy$130.00+22.73%Maintains
a month ago
Caredx IncCDNA
9Strong Buy$60.00+11.46%Maintains
a month ago
Caris Life Sciences IncCAI
4Strong Buy$33.00+10.07%Maintains
a month ago
Exagen IncXGN
9Strong Buy$9.00+7.02%Maintains
2 months ago
Sophia Genetics SaSOPH
7Strong Buy$9.00+9.89%Maintains
2 months ago
Genedx Holdings CorpWGS
12Strong Buy$90.00-10.98%Reiterates
2 months ago
Castle Biosciences IncCSTL
6Strong Buy$44.00+24.50%Maintains
2 months ago
Adaptive Biotechnologies CorpADPT
10Strong Buy$25.00-12.62%Maintains
2 months ago
Personalis IncPSNL
7Strong Buy$16.25-0.91%Maintains
2 months ago
Cerus CorpCERS
2Strong Buy$4.00+50.94%Upgrades
5 months ago
Idexx Laboratories IncIDXX
3Strong Buy$800.00+56.36%Maintains
8 months ago
Zoetis IncZTS
4Strong Buy$160.00+124.09%Reiterates
10 months ago
Exact Sciences CorpEXAS
18HoldN/AN/ADowngrades
10 months ago
Maxcyte IncMXCT
4HoldN/AN/ADowngrades
a year ago
Bionano Genomics IncBNGO
8HoldN/AN/ADowngrades
2 years ago
Akoya Biosciences IncAKYA
3HoldN/AN/ADowngrades
2 years ago
Neogenomics IncNEO
4Strong Buy$21.00N/AMaintains
2 years ago
Dermtech IncDMTKQ
4Strong Buy$2.00N/AMaintains
3 years ago
Talis Biomedical CorpTLIS
3Strong Sell$5.00N/AMaintains
3 years ago
Cue Health IncHLTHQ
4Strong Buy$3.00N/AMaintains
3 years ago
Renalytix PLCRNLXY
3Strong Buy$3.50N/AMaintains
3 years ago
Lumiradx LtdLMDXF
1Strong Buy$4.00N/AMaintains
4 years ago
Phenomex IncCELL
2HoldN/AN/ADowngrades
4 years ago
T2 Biosystems IncTTOO
2HoldN/AN/ADowngrades
4 years ago
Quotient LtdQTNTQ
1Strong Buy$1.50N/AMaintains
4 years ago
Insight Molecular Diagnostics IncIMDX
1Strong Buy$100.00N/AInitiates Coverage On
6 years ago
Chembio Diagnostics IncCEMI
1Strong Buy$12.00N/AMaintains
6 years ago
Labcorp Holdings IncLH
4Hold$155.00N/AMaintains
8 years ago
Genmark Diagnostics IncGNMK
4Strong Buy$9.00N/AMaintains
8 years ago
Quest Diagnostics IncDGX
3Strong Buy$105.00N/AMaintains
8 years ago
Hologic IncHOLX
3Hold$41.00N/AMaintains
8 years ago
Quidelortho CorpQDEL
4Strong Buy$80.00N/AMaintains
8 years ago
Genomic Health IncGHDX
3Strong Buy$62.00N/AMaintains
8 years ago
Illumina IncILMN
3Strong Buy$340.00N/AMaintains
8 years ago
Heska CorpHSKA
2Strong Buy$123.00N/AMaintains
8 years ago
Htg Molecular Diagnostics IncHTGMQ
2Strong Buy$1,260.00N/AMaintains
8 years ago
Abaxis IncABAX
1Hold$47.00N/AMaintains
9 years ago
Alerislife IncALR
2HoldN/AN/ADowngrades
9 years ago
Alere IncALR1
4Hold$56.00N/ADowngrades
11 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.